Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin

The requested reference [70c116cf7f42bffe40406b5650c6bb53063ff609] no longer exists in our database. It has been replaced by the current reference: [ad0e426fe6e7dc5884237938fb0e43ae0b638651]

Authors
Category Primary study
JournalThe Korean Journal of Internal Medicine
Year 2014
Various adverse events have been reported during combination therapy with pegylated (PEG)-interferon-alpha and ribavirin, although opportunistic infections, especially cryptococcal meningitis, are very rare. A 61-year-old woman complained of headaches and a fever during treatment of a chronic hepatitis C virus (HCV) infection. She had been treated for 7 months. Her headaches were refractory to analgesics, and she developed subtle nuchal rigidity. The cerebral spinal fluid (CSF) revealed a white blood cell count of 205/mm3, 51 mg/dL protein, 35 mg/dL glucose, and negative Cryptococcus antigen. The CSF culture resulted in no growth. Five days later, the CSF was positive for Cryptococcus antigen. We administered amphotericin B and flucytosine, followed by fluconazole. Approximately 2 months later, she was discharged. For the first time, we report a case of cryptococcal meningitis during the treatment of chronic HCV with PEG-interferon-alpha and ribavirin.
Epistemonikos ID: a51a17ac957a25a113cf1ed57cbc160598960cc2
First added on: Nov 28, 2024